ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Haemophilia Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1P10415
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Haemophilia Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Haemophilia Drug Market Research Report 2025

Code: QYRE-Auto-1P10415
Report
July 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Novo Nordisk
Pfizer Inc
Roche
Baxter
Sinopharm
Shanghai RAAS Blood Products
China Biologic Products
Hualan Bio
Shanxi Kangbao Biological
CTTQ
CGE Healthcare
Sinocelltech Group
Shire (Baxter)
CSL Limited
Grifols S A
Biogen
Octapharma AG
Kedrion S p A
BPL
GC Biopharma
Belief BioMed
AryoGen Pharmed
Generium
LFB SA

Haemophilia Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Haemophilia Drug Market

Haemophilia Drug Market

The global market for Haemophilia Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Haemophilia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilia Drug.
The Haemophilia Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Haemophilia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Haemophilia Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Haemophilia Drug Market Report

Report Metric Details
Report Name Haemophilia Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Haemophilia A
  • Haemophilia B
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shire (Baxter), CSL, Grifols, Biogen, Octapharma, Kedrion, BPL, Bayer, Novo Nordisk, Pfizer, Roche, Baxter, Sinopharm, Shanghai Raas Blood Products, China Biologic Products, Hualan Bio, CGE Healthcare, Sinocelltech Group, Shanxi Kangbao Biological, CTTQ, GC Biopharma, Belief BioMed, AryoGen Pharmed, GENERIUM, LFB SA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Haemophilia Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Haemophilia Drug Market report?

Ans: The main players in the Haemophilia Drug Market are Shire (Baxter), CSL, Grifols, Biogen, Octapharma, Kedrion, BPL, Bayer, Novo Nordisk, Pfizer, Roche, Baxter, Sinopharm, Shanghai Raas Blood Products, China Biologic Products, Hualan Bio, CGE Healthcare, Sinocelltech Group, Shanxi Kangbao Biological, CTTQ, GC Biopharma, Belief BioMed, AryoGen Pharmed, GENERIUM, LFB SA

What are the Application segmentation covered in the Haemophilia Drug Market report?

Ans: The Applications covered in the Haemophilia Drug Market report are Haemophilia A, Haemophilia B, Others

What are the Type segmentation covered in the Haemophilia Drug Market report?

Ans: The Types covered in the Haemophilia Drug Market report are Blood-derived Coagulation Factor, Recombinant Coagulation Factor

Recommended Reports

Blood Disorders Drugs

Pharmaceutical Testing

Drug Disease Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Haemophilia Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood-derived Coagulation Factor
1.2.3 Recombinant Coagulation Factor
1.3 Market by Application
1.3.1 Global Haemophilia Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Haemophilia A
1.3.3 Haemophilia B
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Haemophilia Drug Market Perspective (2020-2031)
2.2 Global Haemophilia Drug Growth Trends by Region
2.2.1 Global Haemophilia Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Haemophilia Drug Historic Market Size by Region (2020-2025)
2.2.3 Haemophilia Drug Forecasted Market Size by Region (2026-2031)
2.3 Haemophilia Drug Market Dynamics
2.3.1 Haemophilia Drug Industry Trends
2.3.2 Haemophilia Drug Market Drivers
2.3.3 Haemophilia Drug Market Challenges
2.3.4 Haemophilia Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Haemophilia Drug Players by Revenue
3.1.1 Global Top Haemophilia Drug Players by Revenue (2020-2025)
3.1.2 Global Haemophilia Drug Revenue Market Share by Players (2020-2025)
3.2 Global Haemophilia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Haemophilia Drug Revenue
3.4 Global Haemophilia Drug Market Concentration Ratio
3.4.1 Global Haemophilia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Haemophilia Drug Revenue in 2024
3.5 Global Key Players of Haemophilia Drug Head office and Area Served
3.6 Global Key Players of Haemophilia Drug, Product and Application
3.7 Global Key Players of Haemophilia Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Haemophilia Drug Breakdown Data by Type
4.1 Global Haemophilia Drug Historic Market Size by Type (2020-2025)
4.2 Global Haemophilia Drug Forecasted Market Size by Type (2026-2031)
5 Haemophilia Drug Breakdown Data by Application
5.1 Global Haemophilia Drug Historic Market Size by Application (2020-2025)
5.2 Global Haemophilia Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Haemophilia Drug Market Size (2020-2031)
6.2 North America Haemophilia Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Haemophilia Drug Market Size by Country (2020-2025)
6.4 North America Haemophilia Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Haemophilia Drug Market Size (2020-2031)
7.2 Europe Haemophilia Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Haemophilia Drug Market Size by Country (2020-2025)
7.4 Europe Haemophilia Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Haemophilia Drug Market Size (2020-2031)
8.2 Asia-Pacific Haemophilia Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Haemophilia Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Haemophilia Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Haemophilia Drug Market Size (2020-2031)
9.2 Latin America Haemophilia Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Haemophilia Drug Market Size by Country (2020-2025)
9.4 Latin America Haemophilia Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Haemophilia Drug Market Size (2020-2031)
10.2 Middle East & Africa Haemophilia Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Haemophilia Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Haemophilia Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shire (Baxter)
11.1.1 Shire (Baxter) Company Details
11.1.2 Shire (Baxter) Business Overview
11.1.3 Shire (Baxter) Haemophilia Drug Introduction
11.1.4 Shire (Baxter) Revenue in Haemophilia Drug Business (2020-2025)
11.1.5 Shire (Baxter) Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Haemophilia Drug Introduction
11.2.4 CSL Revenue in Haemophilia Drug Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Haemophilia Drug Introduction
11.3.4 Grifols Revenue in Haemophilia Drug Business (2020-2025)
11.3.5 Grifols Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Haemophilia Drug Introduction
11.4.4 Biogen Revenue in Haemophilia Drug Business (2020-2025)
11.4.5 Biogen Recent Development
11.5 Octapharma
11.5.1 Octapharma Company Details
11.5.2 Octapharma Business Overview
11.5.3 Octapharma Haemophilia Drug Introduction
11.5.4 Octapharma Revenue in Haemophilia Drug Business (2020-2025)
11.5.5 Octapharma Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Details
11.6.2 Kedrion Business Overview
11.6.3 Kedrion Haemophilia Drug Introduction
11.6.4 Kedrion Revenue in Haemophilia Drug Business (2020-2025)
11.6.5 Kedrion Recent Development
11.7 BPL
11.7.1 BPL Company Details
11.7.2 BPL Business Overview
11.7.3 BPL Haemophilia Drug Introduction
11.7.4 BPL Revenue in Haemophilia Drug Business (2020-2025)
11.7.5 BPL Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Haemophilia Drug Introduction
11.8.4 Bayer Revenue in Haemophilia Drug Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Haemophilia Drug Introduction
11.9.4 Novo Nordisk Revenue in Haemophilia Drug Business (2020-2025)
11.9.5 Novo Nordisk Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Haemophilia Drug Introduction
11.10.4 Pfizer Revenue in Haemophilia Drug Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Haemophilia Drug Introduction
11.11.4 Roche Revenue in Haemophilia Drug Business (2020-2025)
11.11.5 Roche Recent Development
11.12 Baxter
11.12.1 Baxter Company Details
11.12.2 Baxter Business Overview
11.12.3 Baxter Haemophilia Drug Introduction
11.12.4 Baxter Revenue in Haemophilia Drug Business (2020-2025)
11.12.5 Baxter Recent Development
11.13 Sinopharm
11.13.1 Sinopharm Company Details
11.13.2 Sinopharm Business Overview
11.13.3 Sinopharm Haemophilia Drug Introduction
11.13.4 Sinopharm Revenue in Haemophilia Drug Business (2020-2025)
11.13.5 Sinopharm Recent Development
11.14 Shanghai Raas Blood Products
11.14.1 Shanghai Raas Blood Products Company Details
11.14.2 Shanghai Raas Blood Products Business Overview
11.14.3 Shanghai Raas Blood Products Haemophilia Drug Introduction
11.14.4 Shanghai Raas Blood Products Revenue in Haemophilia Drug Business (2020-2025)
11.14.5 Shanghai Raas Blood Products Recent Development
11.15 China Biologic Products
11.15.1 China Biologic Products Company Details
11.15.2 China Biologic Products Business Overview
11.15.3 China Biologic Products Haemophilia Drug Introduction
11.15.4 China Biologic Products Revenue in Haemophilia Drug Business (2020-2025)
11.15.5 China Biologic Products Recent Development
11.16 Hualan Bio
11.16.1 Hualan Bio Company Details
11.16.2 Hualan Bio Business Overview
11.16.3 Hualan Bio Haemophilia Drug Introduction
11.16.4 Hualan Bio Revenue in Haemophilia Drug Business (2020-2025)
11.16.5 Hualan Bio Recent Development
11.17 CGE Healthcare
11.17.1 CGE Healthcare Company Details
11.17.2 CGE Healthcare Business Overview
11.17.3 CGE Healthcare Haemophilia Drug Introduction
11.17.4 CGE Healthcare Revenue in Haemophilia Drug Business (2020-2025)
11.17.5 CGE Healthcare Recent Development
11.18 Sinocelltech Group
11.18.1 Sinocelltech Group Company Details
11.18.2 Sinocelltech Group Business Overview
11.18.3 Sinocelltech Group Haemophilia Drug Introduction
11.18.4 Sinocelltech Group Revenue in Haemophilia Drug Business (2020-2025)
11.18.5 Sinocelltech Group Recent Development
11.19 Shanxi Kangbao Biological
11.19.1 Shanxi Kangbao Biological Company Details
11.19.2 Shanxi Kangbao Biological Business Overview
11.19.3 Shanxi Kangbao Biological Haemophilia Drug Introduction
11.19.4 Shanxi Kangbao Biological Revenue in Haemophilia Drug Business (2020-2025)
11.19.5 Shanxi Kangbao Biological Recent Development
11.20 CTTQ
11.20.1 CTTQ Company Details
11.20.2 CTTQ Business Overview
11.20.3 CTTQ Haemophilia Drug Introduction
11.20.4 CTTQ Revenue in Haemophilia Drug Business (2020-2025)
11.20.5 CTTQ Recent Development
11.21 GC Biopharma
11.21.1 GC Biopharma Company Details
11.21.2 GC Biopharma Business Overview
11.21.3 GC Biopharma Haemophilia Drug Introduction
11.21.4 GC Biopharma Revenue in Haemophilia Drug Business (2020-2025)
11.21.5 GC Biopharma Recent Development
11.22 Belief BioMed
11.22.1 Belief BioMed Company Details
11.22.2 Belief BioMed Business Overview
11.22.3 Belief BioMed Haemophilia Drug Introduction
11.22.4 Belief BioMed Revenue in Haemophilia Drug Business (2020-2025)
11.22.5 Belief BioMed Recent Development
11.23 AryoGen Pharmed
11.23.1 AryoGen Pharmed Company Details
11.23.2 AryoGen Pharmed Business Overview
11.23.3 AryoGen Pharmed Haemophilia Drug Introduction
11.23.4 AryoGen Pharmed Revenue in Haemophilia Drug Business (2020-2025)
11.23.5 AryoGen Pharmed Recent Development
11.24 GENERIUM
11.24.1 GENERIUM Company Details
11.24.2 GENERIUM Business Overview
11.24.3 GENERIUM Haemophilia Drug Introduction
11.24.4 GENERIUM Revenue in Haemophilia Drug Business (2020-2025)
11.24.5 GENERIUM Recent Development
11.25 LFB SA
11.25.1 LFB SA Company Details
11.25.2 LFB SA Business Overview
11.25.3 LFB SA Haemophilia Drug Introduction
11.25.4 LFB SA Revenue in Haemophilia Drug Business (2020-2025)
11.25.5 LFB SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bayer
Novo Nordisk
Pfizer Inc
Roche
Baxter
Sinopharm
Shanghai RAAS Blood Products
China Biologic Products
Hualan Bio
Shanxi Kangbao Biological
CTTQ
CGE Healthcare
Sinocelltech Group
Shire (Baxter)
CSL Limited
Grifols S A
Biogen
Octapharma AG
Kedrion S p A
BPL
GC Biopharma
Belief BioMed
AryoGen Pharmed
Generium
LFB SA
List of Tables
 Table 1. Global Haemophilia Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blood-derived Coagulation Factor
 Table 3. Key Players of Recombinant Coagulation Factor
 Table 4. Global Haemophilia Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Haemophilia Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Haemophilia Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Haemophilia Drug Market Share by Region (2020-2025)
 Table 8. Global Haemophilia Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Haemophilia Drug Market Share by Region (2026-2031)
 Table 10. Haemophilia Drug Market Trends
 Table 11. Haemophilia Drug Market Drivers
 Table 12. Haemophilia Drug Market Challenges
 Table 13. Haemophilia Drug Market Restraints
 Table 14. Global Haemophilia Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Haemophilia Drug Market Share by Players (2020-2025)
 Table 16. Global Top Haemophilia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2024)
 Table 17. Ranking of Global Top Haemophilia Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Haemophilia Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Haemophilia Drug, Headquarters and Area Served
 Table 20. Global Key Players of Haemophilia Drug, Product and Application
 Table 21. Global Key Players of Haemophilia Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Haemophilia Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Haemophilia Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Haemophilia Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Haemophilia Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Haemophilia Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Haemophilia Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Haemophilia Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Haemophilia Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Haemophilia Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Haemophilia Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Haemophilia Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Haemophilia Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Haemophilia Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Haemophilia Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Haemophilia Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Haemophilia Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Haemophilia Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Haemophilia Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Haemophilia Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Haemophilia Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Haemophilia Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Haemophilia Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Haemophilia Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Shire (Baxter) Company Details
 Table 47. Shire (Baxter) Business Overview
 Table 48. Shire (Baxter) Haemophilia Drug Product
 Table 49. Shire (Baxter) Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 50. Shire (Baxter) Recent Development
 Table 51. CSL Company Details
 Table 52. CSL Business Overview
 Table 53. CSL Haemophilia Drug Product
 Table 54. CSL Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 55. CSL Recent Development
 Table 56. Grifols Company Details
 Table 57. Grifols Business Overview
 Table 58. Grifols Haemophilia Drug Product
 Table 59. Grifols Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 60. Grifols Recent Development
 Table 61. Biogen Company Details
 Table 62. Biogen Business Overview
 Table 63. Biogen Haemophilia Drug Product
 Table 64. Biogen Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 65. Biogen Recent Development
 Table 66. Octapharma Company Details
 Table 67. Octapharma Business Overview
 Table 68. Octapharma Haemophilia Drug Product
 Table 69. Octapharma Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 70. Octapharma Recent Development
 Table 71. Kedrion Company Details
 Table 72. Kedrion Business Overview
 Table 73. Kedrion Haemophilia Drug Product
 Table 74. Kedrion Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 75. Kedrion Recent Development
 Table 76. BPL Company Details
 Table 77. BPL Business Overview
 Table 78. BPL Haemophilia Drug Product
 Table 79. BPL Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 80. BPL Recent Development
 Table 81. Bayer Company Details
 Table 82. Bayer Business Overview
 Table 83. Bayer Haemophilia Drug Product
 Table 84. Bayer Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 85. Bayer Recent Development
 Table 86. Novo Nordisk Company Details
 Table 87. Novo Nordisk Business Overview
 Table 88. Novo Nordisk Haemophilia Drug Product
 Table 89. Novo Nordisk Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 90. Novo Nordisk Recent Development
 Table 91. Pfizer Company Details
 Table 92. Pfizer Business Overview
 Table 93. Pfizer Haemophilia Drug Product
 Table 94. Pfizer Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 95. Pfizer Recent Development
 Table 96. Roche Company Details
 Table 97. Roche Business Overview
 Table 98. Roche Haemophilia Drug Product
 Table 99. Roche Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 100. Roche Recent Development
 Table 101. Baxter Company Details
 Table 102. Baxter Business Overview
 Table 103. Baxter Haemophilia Drug Product
 Table 104. Baxter Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 105. Baxter Recent Development
 Table 106. Sinopharm Company Details
 Table 107. Sinopharm Business Overview
 Table 108. Sinopharm Haemophilia Drug Product
 Table 109. Sinopharm Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 110. Sinopharm Recent Development
 Table 111. Shanghai Raas Blood Products Company Details
 Table 112. Shanghai Raas Blood Products Business Overview
 Table 113. Shanghai Raas Blood Products Haemophilia Drug Product
 Table 114. Shanghai Raas Blood Products Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 115. Shanghai Raas Blood Products Recent Development
 Table 116. China Biologic Products Company Details
 Table 117. China Biologic Products Business Overview
 Table 118. China Biologic Products Haemophilia Drug Product
 Table 119. China Biologic Products Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 120. China Biologic Products Recent Development
 Table 121. Hualan Bio Company Details
 Table 122. Hualan Bio Business Overview
 Table 123. Hualan Bio Haemophilia Drug Product
 Table 124. Hualan Bio Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 125. Hualan Bio Recent Development
 Table 126. CGE Healthcare Company Details
 Table 127. CGE Healthcare Business Overview
 Table 128. CGE Healthcare Haemophilia Drug Product
 Table 129. CGE Healthcare Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 130. CGE Healthcare Recent Development
 Table 131. Sinocelltech Group Company Details
 Table 132. Sinocelltech Group Business Overview
 Table 133. Sinocelltech Group Haemophilia Drug Product
 Table 134. Sinocelltech Group Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 135. Sinocelltech Group Recent Development
 Table 136. Shanxi Kangbao Biological Company Details
 Table 137. Shanxi Kangbao Biological Business Overview
 Table 138. Shanxi Kangbao Biological Haemophilia Drug Product
 Table 139. Shanxi Kangbao Biological Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 140. Shanxi Kangbao Biological Recent Development
 Table 141. CTTQ Company Details
 Table 142. CTTQ Business Overview
 Table 143. CTTQ Haemophilia Drug Product
 Table 144. CTTQ Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 145. CTTQ Recent Development
 Table 146. GC Biopharma Company Details
 Table 147. GC Biopharma Business Overview
 Table 148. GC Biopharma Haemophilia Drug Product
 Table 149. GC Biopharma Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 150. GC Biopharma Recent Development
 Table 151. Belief BioMed Company Details
 Table 152. Belief BioMed Business Overview
 Table 153. Belief BioMed Haemophilia Drug Product
 Table 154. Belief BioMed Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 155. Belief BioMed Recent Development
 Table 156. AryoGen Pharmed Company Details
 Table 157. AryoGen Pharmed Business Overview
 Table 158. AryoGen Pharmed Haemophilia Drug Product
 Table 159. AryoGen Pharmed Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 160. AryoGen Pharmed Recent Development
 Table 161. GENERIUM Company Details
 Table 162. GENERIUM Business Overview
 Table 163. GENERIUM Haemophilia Drug Product
 Table 164. GENERIUM Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 165. GENERIUM Recent Development
 Table 166. LFB SA Company Details
 Table 167. LFB SA Business Overview
 Table 168. LFB SA Haemophilia Drug Product
 Table 169. LFB SA Revenue in Haemophilia Drug Business (2020-2025) & (US$ Million)
 Table 170. LFB SA Recent Development
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. Authors List of This Report


List of Figures
 Figure 1. Haemophilia Drug Picture
 Figure 2. Global Haemophilia Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Haemophilia Drug Market Share by Type: 2024 VS 2031
 Figure 4. Blood-derived Coagulation Factor Features
 Figure 5. Recombinant Coagulation Factor Features
 Figure 6. Global Haemophilia Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Haemophilia Drug Market Share by Application: 2024 VS 2031
 Figure 8. Haemophilia A Case Studies
 Figure 9. Haemophilia B Case Studies
 Figure 10. Others Case Studies
 Figure 11. Haemophilia Drug Report Years Considered
 Figure 12. Global Haemophilia Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Haemophilia Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Haemophilia Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global Haemophilia Drug Market Share by Players in 2024
 Figure 16. Global Top Haemophilia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Haemophilia Drug Revenue in 2024
 Figure 18. North America Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Haemophilia Drug Market Share by Country (2020-2031)
 Figure 20. United States Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Haemophilia Drug Market Share by Country (2020-2031)
 Figure 24. Germany Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Haemophilia Drug Market Share by Region (2020-2031)
 Figure 32. China Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Haemophilia Drug Market Share by Country (2020-2031)
 Figure 40. Mexico Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Haemophilia Drug Market Share by Country (2020-2031)
 Figure 44. Turkey Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Haemophilia Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Shire (Baxter) Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 48. CSL Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 49. Grifols Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 50. Biogen Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 51. Octapharma Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 52. Kedrion Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 53. BPL Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 54. Bayer Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 55. Novo Nordisk Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 56. Pfizer Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 57. Roche Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 58. Baxter Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 59. Sinopharm Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 60. Shanghai Raas Blood Products Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 61. China Biologic Products Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 62. Hualan Bio Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 63. CGE Healthcare Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 64. Sinocelltech Group Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 65. Shanxi Kangbao Biological Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 66. CTTQ Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 67. GC Biopharma Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 68. Belief BioMed Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 69. AryoGen Pharmed Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 70. GENERIUM Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 71. LFB SA Revenue Growth Rate in Haemophilia Drug Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Hemophilia A Drug Market Research Report 2024
Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Research Report 2025
Blood thinning Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemorrhagic Shock Treatment Market Research Report 2025
Global Anticoagulant Medicine Market Research Report 2025
Hematological Malignancy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sickle Cell Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dengue Fever Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Postpartum Hemorrhage PPH Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemoglobinopathies Drugs Market Research Report 2024
Global IVD Raw Materials Market Insights Forecast to 2030
Hematological Malignancies Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ant Killer Market Research Report 2024
Global Still s Disease Treatment Market Research Report 2025
Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Drugs Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions